Sentiment appears to be at an all time low for Anteotech, with...

Sentiment appears to be at an all time low for Anteotech, with optimism for the future in short supply.

This would not go unnoticed by the SII, and I suspect the largest vaccine manufacturer in the world might be dropping into Eight Mile Plains this month to check out the viability of the business and its ongoing access to a regular supply of Anteobind.

Our ex CEO said "We are excited to extend our close working relationship with Serum Institute of India, one of the leaders and innovators in the global vaccine market, with our unique AnteoBindTM product becoming an integral part of their vaccine development and production process" and "Both AnteoTech and Serum Institute of India have structured this supply agreement to maintain ongoing and minimum supply levels of the Product, over the life of the Serum Institute of India’s new vaccine products, which are typically 20 years following regulatory approval."

SII would not want to jeopardise their regulatory approval process by partnering with a company teetering on the brink of extinction. Would be small change for the SII to secure an integral part their supply chain with a buyout of the entire life science division of ADO. Perhaps the review currently underway might come up with some creative options to maintain what for Anteo has been the most prestigious and lucrative relationship thus far.